Abstract: Disclosed are medicated cleansing pads comprising: (a) from about 50% to about 75% of a nonwoven fabric material; (b) from about 20% to about 75% (on a dry solids basis) of a water soluble polymeric resin of the formula:(A.sub.x).sbsb.m (B.sub.y).sbsb.nwherein A is one or more monomers selected from styrene or styrene derivatives and B is one or more monomers selected from butadiene or butadiene derivatives, x is the number of different A monomer components present in the copolymer chain, with x being an integer of 1 or more and y is the number of B monomer components present in the copolymer chain, with y being an integer of 0 or more and m:n is the weight ratio of A monomer components to B monomer components, and is from about 10:1 to about 1:5, preferably from about 5:1 to about 1:2, and (c) from about 0.1% to about 50% of salicylic acid active composition.

Abstract: Disclosed are medicated cleansing pads comprising:(a) from about 50% to about 75% of two or more layers of nonwoven fabric materials;(b) from about 20% to about 75% (on a dry solids basis) of a water soluble polymeric resin of the formula: ##STR1## wherein A is one or more monomers selected from styrene or styrene derivatives and B is one or more monomers selected from butadiene or butadiene derivatives, x is the number of different A monomer components present in the copolymer chain, with x being an integer of 1 or more and y is the number of B monomer components present in the copolymer chain, with y being an integer of 0 or more and m:n is the weight ratio of A monomer components to B monomer components, and is from about 10:1 to about 1:5; and(c) from about 0.1% to about 50.0% of a salicylic acid active composition.This invention also encompasses a method of treating acne in humans and lower animals comprising topically applying to the affected area the medicated pads of the present invention.

Abstract: Antidiarrheal compositions showing enhanced antidiarrheal activity comprise a non-steroidal anti-inflammatory drug compound and a polymeric hydroabsorptive agent. A patient in need of remedial or preventive treatment of diarrhea symptoms is administered an antidiarrheally effective amount of said antidiarrheal compositions.

Abstract: Pantethine and pantetheine in permanent waving operations for hair to increase waving efficiency.

Abstract: This invention relates to a new composition for washing and conditioning hair, and more particularly a new composition providing both a shampooing and a conditioning action in a single application.

Abstract: Novel pharmaceutical compositions of matter are disclosed for use in eliciting a topical anesthetic and antimicrobial response, preferably for oral health care purposes, said compositions comprising dyclonine hydrochloride and phenol. When used in combination, dyclonine hydrochloride and phenol provide an improved antimicrobial response.

Abstract: A hydroalcoholic solution with pH 2-3.5 of salicylic acid and an anionic taurate surfactant selected from the group consisting of sodium methyl cocoyl taurate and sodium methyl oleoyl taurate.

Abstract: A pressurized aerosol composition containing zeolite, surfactant, water and propellant in prescribed amounts and ratios which, upon discharge from an aerosol container, produces a characteristically dry foam.

Abstract: Zinc and strontium unmixed partial salts of lower alkyl vinyl ether-maleic acid copolymers useful as denture adhesives.

Abstract: Method and pharmaceutical composition for topically treating skin inflammatory disorders by administering to the inflamed area a therapeutically effective amount of candelilla wax or a saturated hydrocarbon fraction from candelilla wax comprising a mixture of saturated straight chain C.sub.29 -C.sub.33 hydrocarbons, predominantly C.sub.31 hydrocarbon.

Abstract: Novel pharmaceutical compositions of matter are provided comprising analgesic/non-steroidal anti-inflammatory drugs and diphenhydramine and methods of using said compositions to elicit an enhanced analgesic and/or anti-inflammatory response in mammalian organisms in need of such treatment.

Abstract: A stable water-in-oil emulsion composition for topical therapeutic administration comprising:a. a dispersed aqueous phase comprising water optionally containing a pharmaceutically acceptable electrolyte dissolved therein;b. a pharmaceutically acceptable continuous oil phase comprising mineral oil and a volatile silicone fluid;c. an organopolysiloxane emulsifier of Formula (I) hereinafter described;d. PPG-20 Methyl Glucose Ether Distearate; ande. an active drug component for topical application.

Abstract: Novel pharmaceutical compositions of matter are provided comprising analgesic/non-steroidal anti-inflammatory drugs and diphenhydramine and methods of using said compositions to elicit an enhanced analgesic and/or anti-inflammatory response in mammalian organisms in need of such treatment.

Abstract: Antidiarrheal compositions showing enhanced antidiarrheal activity comprise a non-steroidal anti-inflammatory drug compound and a polymeric hydroabsorptive agent. A patient in need of remedial or preventive treatment of diarrhea symptoms is administered an antidiarrheally effective amount of said antidiarrheal compositions.

Abstract: A stable aqueous hair conditioning shampoo composition comprising an aqueous solution of hydrogen peroxide, a specific anionic surfactant, at least one nonionic surfactant, an acidic pH-producing agent and one or more hair conditioning components.

Abstract: Preparation being effective against bad breath, particularly caused by strongly smelling food stuffs or cigarettes, alcohol and the like, consisting of cardamom seeds which are individually or jointly coated by a shell mass comprising a sugar mass or the like.

Abstract: Method and pharmaceutical composition for topically treating skin inflammatory disorders by administering to the inflamed area a therapeutically effective amount of a substantially non-polar hydrocarbon fraction from beeswax comprising a mixture of (i) a major proportion of saturated straight chain C.sub.21 -C.sub.33 hydrocarbons and (ii) a minor proportion of mono-unsaturated long chain hydrocarbons.

Abstract: A stabilized clear benzoyl peroxide composition is provided comprising from about 0.1 to about 3.8% by weight anhydrous benzoyl peroxide in C.sub.6 -C.sub.10 triglycerides.